Skip to content

Longitudinal Study on the Influence of Iodine Nutrition Status on Thyroid Function of Childbearing Age Women During Pregnancy and 6 Weeks Postpartum

Longitudinal Study on the Influence of Iodine Nutrition Status on Thyroid Function of Childbearing Age Women During Pregnancy and 6 Weeks Postpartum

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05677581
Enrollment
2100
Registered
2023-01-10
Start date
2023-11-15
Completion date
2024-12-31
Last updated
2024-05-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Iodine Nutrition Status, Thyroid Function

Brief summary

The goal of this observational study is to provide a reference for formulating individual appropriate iodine intake programs for women during pregnancy and postpartum and improving the monitoring and evaluation system of maternal iodine nutrition status. The main questions it aims to answer are: * To analyse the longitudinal changes of urinary iodine, urinary iodine/creatinine ratio, thyroid function and related factors in different periods of early, middle, late pregnancy and 6 weeks postpartum in Beijing area. * To explore the relationship between iodine nutrition status and the changes of thyroid function and to further clarify the effect of iodine nutrition status on thyroid function of women of childbearing age during pregnancy and postpartum in combination with dietary intake of iodine questionnaire. Participants will be detected there thyroid function, the level of median urinary iodine and urinary iodine/creatinine. Researchers will compare healthy women of childbearing age served as the control group in the same period.

Interventions

OTHERiodine nutrition status

iodine nutrition status

Sponsors

Beijing Friendship Hospital
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
FEMALE
Healthy volunteers
Yes

Inclusion criteria

8-12 weeks healthy maternal: Inclusion Criteria: * primigravida * no chronic hypertension, thromboembolic disease, severe gastrointestinal, cardiopulmonary and liver diseases before pregnancy * no systemic lupus erythematosus, rheumatic diseases and other connective tissue diseases or immune diseases before pregnancy * no adrenocortical hyperplasia, pituitary endocrine diseases and other diseases before pregnancy

Exclusion criteria

* multiple pregnancies and multigravida * a history of type I or type II diabetes before pregnancy * a clear history of thyroid diseases before pregnancy * taking drugs that affect thyroid function and/or blood sugar before or during early pregnancy Healthy women of childbearing age: Inclusion Criteria: * 20-40 years old * no chronic hypertension, thromboembolic disease, severe gastrointestinal, cardiopulmonary and liver diseases * no systemic lupus erythematosus, rheumatic diseases and other connective tissue diseases or immune diseases * no adrenocortical hyperplasia, pituitary endocrine diseases and other diseases

Design outcomes

Primary

MeasureTime frameDescription
Data of pregnant women in the early trimester of pregnancyAny day between weeks 8 and 12 of gestationdetect the level of serum TSH, FT4, TPOAb, TGAb and the level of median urinary iodine and urinary iodine/creatinine
Data of pregnant women in the middle trimester of pregnancyAny day between weeks 24 and 28 of gestationdetect the level of serum TSH, FT4, TPOAb, TGAb and the level of median urinary
Data of pregnant women in the third trimester of pregnancyAny day between weeks 36 of gestation to the day before parturitiondetect the level of serum TSH, FT4, TPOAb, TGAb and the level of median urinary
Data of postpartum women6 weeks after parturitiondetect the level of serum TSH, FT4, TPOAb, TGAb and the level of median urinary

Countries

China

Contacts

Primary ContactYan Long, Chief Physician/Professor
longyan_doc@163.com13671148911

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026